Gasochromic tungsten oxide films with PdCl2 solution as an aqueous Hydrogen catalyst

Autor: Hemati, A., Allaf B, M., Ranjbar, M., Kameli, P., Salamati, H.

Publikováno v: In Solar Energy Materials and Solar Cells January 2013 108:105-112

Newborn screening for sickle cell disease in Europe

Autor: Daniel, Y, Elion, J, Allaf, B, Badens, C, Bouva, MJ, Brincat, I, Cela, E, Coppinger, C

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::eb75cfd98905be93552149e50872d96d
http://hdl.handle.net/10029/622933

Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study.

Autor: Papeix C; Département de Neurologie, Hôpital de la Pitié Salpêtrière, APHP 6, 83 Boulevard de l'Hôpital, 75013, Paris, France. caroline.papeix@aphp.fr., Castelnovo G; Service de Neurologie, CHU Carémeau, Nîmes, France., Leray E; EHESP, Rennes, France., Coustans M; Service de Neurologie, Hôpital Laënnec, Quimper, France., Levy P; LEDa, LEGOS, Université Paris-Dauphine, PSL Research University, Paris, France., Visy JM; Polyclinique de Courlancy, Reims, France., Kobelt G; European Health Economics, Stockholm, Sweden., Lamy F; Novartis Pharma S.A.S., Rueil-Malmaison, France., Allaf B; Novartis Pharma S.A.S., Rueil-Malmaison, France., Heintzmann F; Novartis Pharma S.A.S., Rueil-Malmaison, France., Chouette I; Novartis Pharma S.A.S., Rueil-Malmaison, France., Raponi E; Novartis Pharma S.A.S., Rueil-Malmaison, France., Durand B; Novartis Pharma S.A.S., Rueil-Malmaison, France., Grevat E; Novartis Pharma S.A.S., Rueil-Malmaison, France., Kamar D; Ividata Life Science, Levallois-Perret, France., Debouverie M; Service de Neurologie, CHU de Nancy, Nancy, France., Lebrun-Frenay C; Service de Neurologie, UR2CA-URRIS, CRCSEP, Hôpital Pasteur 2, Nice, France.

Publikováno v: Neurology and therapy [Neurol Ther] 2022 Jun; Vol. 11 (2), pp. 633-658. Date of Electronic Publication: 2022 Feb 11.

Gasochromic tungsten oxide films with PdCl2 solution as an aqueous Hydrogen catalyst

Autor: A. Hemati, M. Allaf B, M. Ranjbar, P. Kameli, H. Salamati

Publikováno v: Solar Energy Materials and Solar Cells. 108:105-112

In this study, WO 3 nanostructured films were prepared by sol–gel spin coating process on glass substrates and drops of PdCl 2 solution were used as an aqueous hydrogen catalyst for gasochromic investigations. As deposited WO 3 films were annealed

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::eb5fff863fc280a04db1f79212838c59
https://doi.org/10.1016/j.solmat.2012.08.018

Appropriate thresholds for accurate screening for β-thalassemias in the newborn period: results from a French center for newborn screening.

Autor: Allaf B; AP-HP (Assistance Publique-Hôpitaux de Paris), Robert-Debré Hospital, Newborn Screening Laboratory for Hemoglobinopathies, Paris, France., Pondarre C; Department of General Pediatrics, Reference Center for Sickle Cell Disease, Hospital of Creteil, Créteil, France.; INSERM Unité 955, Paris XII University, Créteil, France., Allali S; AP-HP, Department of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Necker Hospital for Sick Children, Paris Descartes University, Paris, France.; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Paris Descartes - Sorbonne Paris Cite University, Imagine Institute, Inserm U1163, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., De Montalembert M; AP-HP, Department of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Necker Hospital for Sick Children, Paris Descartes University, Paris, France.; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Paris Descartes - Sorbonne Paris Cite University, Imagine Institute, Inserm U1163, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., Arnaud C; Department of General Pediatrics, Reference Center for Sickle Cell Disease, Hospital of Creteil, Créteil, France., Barrey C; Department of Pediatrics, Saint Camille Hospital, Bry-sur-Marne, France., Benkerrou M; Department of Child Hematology, Reference Center for Sickle Cell Disease Robert-Debré University Hospital, APHP, Paris, 75019,France., Benhaim P; AP-HP, Department of Pediatrics, Jean Verdier Hospital, Bondy, France., Bensaid P; Department of Pediatrics, Victor Dupouy Hospital, Argenteuil, France., Brousse V; AP-HP, Department of General Pediatrics and Pediatric Infectious Diseases, Reference Center for Sickle Cell Disease, Necker Hospital for Sick Children, Paris Descartes University, Paris, France.; Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, Paris Descartes - Sorbonne Paris Cite University, Imagine Institute, Inserm U1163, Paris, France.; Laboratory of Excellence GR-Ex, Paris, France., Dollfus C; APHP, Department of Pediatric Hematology-Oncology Armand Trousseau Hospital, Sorbonne University Paris, Paris, France., Eyssette-Guerreau S; Department of Pediatrics, René-Dubos Hospital, Pontoise, France., Galacteros F; AP-HP, Sickle Cell Referral Center, Internal Medicine Unit, IMRB Team 2, UPEC, Labex GRex, Henri Mondor Hospital, Créteil, France., Gajdos V; AP-HP Department of Pediatrics, Antoine Béclère University Hospital, Clamart, France.; Centre for Research in Epidemiology and Population Health, Villejuif, France.; Saclay University, Paris, France., Garrec N; Department of Pediatrics, Marne-la-Vallée Hospital, Jossigny, France., Guillaumat C; Department of Pediatrics, Sud Francilien Hospital, 91100,Corbeil-Essonne, France., Guitton C; AP-HP, Pediatrics Department, Reference Center for Sickle Cell Disease, Bicêtre Hospital, Le Kremlin Bicêtre, France., Monfort-Gouraud M; Department of Pediatrics, Meaux Hospital, Meaux, France., Gouraud F; Department of Pediatrics, Meaux Hospital, Meaux, France., Holvoet L; Department of Child Hematology, Reference Center for Sickle Cell Disease Robert-Debré University Hospital, APHP, Paris, 75019,France., Ithier G; Department of Child Hematology, Reference Center for Sickle Cell Disease Robert-Debré University Hospital, APHP, Paris, 75019,France., Kamdem A; Department of General Pediatrics, Reference Center for Sickle Cell Disease, Hospital of Creteil, Créteil, France., Koehl B; Department of Child Hematology, Reference Center for Sickle Cell Disease Robert-Debré University Hospital, APHP, Paris, 75019,France., Malric A; Department of Pediatrics, Saint-Denis Hospital, Saint-Denis, France., Missud F; Department of Child Hematology, Reference Center for Sickle Cell Disease Robert-Debré University Hospital, APHP, Paris, 75019,France., Monier B; Department of Pediatrics, Simone Veil Hospital, Montmorency, France., Odièvre MH; AP-HP, Department of General Pediatrics and Pediatric Infectious Diseases, Center for Sickle Cell Disease, Armand Trousseau Hospital, Sorbonne Université, Paris, France., Joly P; Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Equipe 'Biologie vasculaire et du globule rouge', Université Claude Bernard Lyon 1, COMUE Lyon, Villeurbanne, France.; Laboratoire d'Excellence du Globule Rouge (Labex GR-Ex), PRES Sorbonne, Paris, France.; UF Biochimie des pathologies érythrocytaires, Laboratoire de Biochimie et Biologie moléculaire Grand-Est, Groupement hospitalier Est, Hospices Civils de Lyon, Bron, France., Renoux C; Laboratoire Interuniversitaire de Biologie de la Motricité (LIBM) EA7424, Equipe 'Biologie vasculaire et du globule rouge', Université Claude Bernard Lyon 1, COMUE Lyon, Villeurbanne, France.; Laboratoire d'Excellence du Globule Rouge (Labex GR-Ex), PRES Sorbonne, Paris, France.; UF Biochimie des pathologies érythrocytaires, Laboratoire de Biochimie et Biologie moléculaire Grand-Est, Groupement hospitalier Est, Hospices Civils de Lyon, Bron, France., Patin F; AP-HP (Assistance Publique-Hôpitaux de Paris), Robert-Debré Hospital, Newborn Screening Laboratory for Hemoglobinopathies, Paris, France., Pissard S; Laboratory of Excellence GR-Ex, Paris, France.; Institut National de la Sante et de la Recherche Médicale (INSERM) U 955 eq 2, Institut Mondor de Recherche Biomoléculaire (IMRB), Paris, France.; APHP, Molecular Genetics Department, Henri Mondor Hospital, Créteil, France., Couque N; AP-HP, Robert-Debré, Molecular Genetics Department, Paris, France.

Publikováno v: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2020 Aug 19; Vol. 59 (1), pp. 209-216. Date of Electronic Publication: 2020 Aug 19.